CHUGAI PHARMACEUTICAL CO., LTD.

Print

Translation

Feb 03, 2010

Name of listed company:   Chugai Pharmaceutical Co., Ltd.
Code number: 4519 (1st Section of Tokyo Stock Exchange)
Head office: 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo
President & CEO: Osamu Nagayama
Inquiries to: Nobuyuki Chiba,
General Manager, Corporate Communications Dept.
  Tel:+81-(0)3-3273-0881

Appointments of Directors

Chugai Pharmaceutical Co., Ltd. [Head Office: Chuo-ku, Tokyo; President Osamu Nagayama] announces new appointments as of March 25, 2010. The details are as follows.

Appointment of Directors

Name New Responsibilities Old Responsibilities
Tatsuro Kosaka Director, Executive Vice President Senior Vice President
Yasuo Ikeda Director  
Pascal Soriot Director  
Jean-Jacques Garaud Director  
  • The appointments of Tatsuro Kosaka, Yasuo Ikeda, Pascal Soriot and Jean-Jacques Garaud as directors are subject to approval at the 99th Annual General Meeting of Shareholders, which is scheduled to be convened on March 25, 2010.
  • Harutaka Fujita, Christopher Murray, Naotaka Nakamura and Severin Schwan are scheduled to retire from the Board of Directors as of March 25, 2010.
  • Naotaka Nakamura is going to take the role of Executive Vice President.
  • Christopher Murray is going to take the role of Full-time Senior Advisor.

[ PDF 12KB]

To view PDF files,
you will need Adobe® Reader® which is available as a free download.

Close